Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.40
+0.60 (1.59%)
Aug 12, 2025, 1:28 PM CST

New Relic Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
4,9576,82910,3147,055--
Upgrade
Market Cap Growth
-40.90%-33.79%46.18%---
Upgrade
Enterprise Value
3,7715,3389,3306,778--
Upgrade
Last Close Price
38.4052.9088.0062.22--
Upgrade
PE Ratio
--1219.72---
Upgrade
PS Ratio
28.5540.7532.80---
Upgrade
PB Ratio
2.903.529.079.27--
Upgrade
P/TBV Ratio
2.903.539.079.27--
Upgrade
P/OCF Ratio
--327.98---
Upgrade
EV/Sales Ratio
21.7231.8629.67---
Upgrade
EV/EBITDA Ratio
--3121.44---
Upgrade
Debt / Equity Ratio
0.060.060.130.030.070.31
Upgrade
Debt / EBITDA Ratio
--7.04---
Upgrade
Asset Turnover
0.080.100.30---
Upgrade
Inventory Turnover
1.361.74----
Upgrade
Quick Ratio
13.4914.0312.5824.2313.964.18
Upgrade
Current Ratio
14.2714.4813.0224.6514.394.31
Upgrade
Return on Equity (ROE)
-15.22%-10.84%0.89%-41.24%-54.73%-103.22%
Upgrade
Return on Assets (ROA)
-8.46%-7.81%-0.17%-24.49%-28.67%-35.08%
Upgrade
Return on Capital (ROIC)
-8.86%-8.19%-0.17%-25.13%-29.48%-36.52%
Upgrade
Earnings Yield
-5.69%-2.44%0.08%-3.78%--
Upgrade
FCF Yield
-8.74%-4.28%-0.48%-3.81%--
Upgrade
Buyback Yield / Dilution
-7.59%-11.49%-15.09%-16.02%-78.34%-27.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.